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conditions and temperatures
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Robert de Jonge b, and Sandra G. Heil a
aDepartment of Clinical Chemistry, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands; bDepartment of Clinical 
Chemistry, Amsterdam Gastroenterology and Metabolism, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
ABSTRACT
Background: Epigenetic markers are often quantified and related to disease in stored samples. 
While, effects of storage on stability of these markers have not been thoroughly examined. In this 
longitudinal study, we investigated the influence of storage time, material, temperature, and 
freeze-thaw cycles on stability of global DNA (hydroxy)methylation. Methods: EDTA blood was 
collected from 90 individuals. Blood (n = 30, group 1) and extracted DNA (n = 30, group 2) were 
stored at 4°C, −20°C and −80°C for 0, 1 (endpoint blood 4°C), 6, 12 or 18 months. Additionally, 
freeze-thaw cycles of blood and DNA samples (n = 30, group 3) were performed over three days. 
Global DNA methylation and hydroxymethylation (mean ± SD) were quantified using liquid 
chromatography–electrospray ionization–tandem mass spectrometry (LC-ESI-MS/MS) with 
between-run precision of 2.8% (methylation) and 6.3% (hydroxymethylation). Effects on stability 
were assessed using linear mixed models. Results: global DNA methylation was stable over 
18 months in blood at −20°C and −80°C and DNA at 4°C and −80°C. However, at 18 months 
DNA methylation from DNA stored at −20°C relatively decreased −6.1% compared to baseline. 
Global DNA hydroxymethylation was more stable in DNA samples compared to blood, indepen-
dent of temperature (p = 0.0131). Stability of global DNA methylation and hydroxymethylation 
was not affected up to three freeze – thaw cycles. Conclusion: Global DNA methylation and 
hydroxymethylation stored as blood and DNA can be used for epigenetic studies. The relevance 
of  small differences occuring during storage depend on the expected effect size and research 
question.
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Introduction
With the introduction of the term ‘epigenetics’ and 
the development of more accurate techniques to 
quantify epigenetic changes, this field has gained 
more interest over the last thirty years [1]. 
Epigenetics comprises the reversible process of 
DNA and histone modifications that alter gene 
expression without changing the DNA sequence. 
DNA methylation is the most studied epigenetic 
modification, which involves the addition of a CH3 
group to the DNA, which is in humans predomi-
nantly found on cytosines (5-methylcytosine; 5mC) 
[2]. DNA methylation can be actively de-methylated 
through the oxidation by Ten-eleven-Translocation 
(TET) enzymes to 5-hydroxymethylcytosine (5hmC) 
which can also act as an epigenetic modifier itself 
[3,4]. DNA methylation and hydroxymethylation 
have previously been associated with several diseases 
like cancer, heart disease, autoimmune diseases, and 
neurological disorders [5–10], and are therefore 
potential biomarkers for disease onset, progression, 
or response to medication [11]. DNA is required for 
epigenetic studies, which is mainly extracted from 
blood samples that have been collected from patients 
over several years and has therefore been stored for 
different time periods prior to the start of a study. 
Despite the increasing number of studies that relate 
differences in DNA (hydroxy)methylation to disease, 
only a handful of studies have examined the effect of 
storage material and temperature on the stability of 
global DNA methylation over longer storage dura-
tion. These studies, focused either at DNA methyla-
tion of targeted regions for specific research 
questions or only included a few subjects [12–18]. 
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Stability of DNA hydroxymethylation was examined 
in even fewer studies. An increase in DNA hydro-
xymethylation was observed at two different sites in 
brain tissue of Alzheimer patients compared to age- 
matched controls [19], which was not influenced by 
tissue storage time. Unfortunately, storage duration 
and temperature were not specified in this study.
In this longitudinal study, we examined the 
stability of global DNA methylation and DNA 
hydroxymethylation in EDTA blood and extracted 
DNA samples at three different temperatures (4°C, 
−20°C, −80°C) for the duration of 0, 1, 6, 12 and 
18 months. Additionally, we investigated the effect 
of freeze-thaw cycles on the stability of global 
DNA (hydroxy)methylation.
Results
Stability over time and under different storage 
conditions
Global DNA methylation
The effects of storage time, temperature, and mate-
rial were assessed in the same model showing that 
global DNA methylation significantly changed over 
time, as the model including the time variable 
(Akaike information criterion; AIC = −819.06) sig-
nificantly better fit the data (p < 0.0001) than the 
model without time variable (AIC = −685.23). To 
assess whether this significant change over time was 
affected by the type of material or storage tempera-
ture a three-way interaction between time, material, 
and temperature was performed, which was signifi-
cant (p < 0.0001; Supplementary Table S1), indicat-
ing that DNA methylation evolved significantly 
different over time between blood and DNA samples 
and between samples stored at different tempera-
tures. Global DNA methylation was not significantly 
different in blood and DNA samples stored at 4°C 
(when compared over 1 month), nor between blood 
and DNA samples stored at −80°C (compared over 
18 months) (Figure 2; Supplementary Table S2). 
Global DNA methylation in blood and DNA sam-
ples was stable at −20°C up to 12 months (Figure 2). 
However, after 12 months mean global DNA methy-
lation in DNA samples stored at −20°C decreased 
and slightly deviated from the slope of EDTA blood 
samples (Figure 2; Supplementary Table S2). After 
18 months, mean global DNA methylation in these 
DNA samples was 4.15 ± 0.23, which is a relative 
decrease of 6.1% compared to baseline (4.42 ± 0.11). 
In all other conditions, relative differences fluctuated 
between 0.5% and 4.1% compared to baseline 
(Supplementary Table S2), which is more compar-
able to the precision of the method (coefficient of 
variation; CV% = 2.3%).
Global DNA hydroxymethylation
The influence of time, material, and temperature on 
the stability of global DNA hydroxymethylation was 
assessed in a linear mixed model. Global DNA 
hydroxymethylation changed significantly over 
time as the AIC of the model including time variable 
(AIC = −5944.98) fit the data significantly better 
(p < 0.0001) compared to the model without time 
variable (AIC = −5920.03). Changes over time were 
significantly different for blood and DNA samples, 
which is described by the significant two-way inter-
action between time and material (p = 0.0131; 
Supplementary Table S1), but independent of sto-
rage temperature, as a three-way interaction between 
time, material, and storage was not significant and 
therefore excluded from the model (Supplementary 
Table S1). Up to 6 months of storage, there was no 
difference in global DNA hydroxymethylation 
between blood and DNA samples (Figure 2). 
However, global DNA hydroxymethylation slightly 
increased in blood samples after 6 months but did 
not change in DNA samples (Figure 2). Over 
12 months, mean global DNA hydroxymethylation 
in blood samples stored at −20°C and −80°C 
increased to 0.040 ± 0.007 and 0.039 ± 0.008, respec-
tively, which are relative changes of 17.6% and 14.7% 
compared to baseline (0.034 ± 0.005). Global DNA 
hydroxymethylation stored at −20°C also increased 
relatively with 12.5% at 12 months compared to 
baseline. Under all other conditions, differences 
over time were smaller and fluctuated between 
0.0% and 9.4% relative to baseline. After 12 months, 
global DNA hydroxymethylation in blood and DNA 
samples stored at these temperatures decreased again 
to a relative difference of ≤6.3% compared to base-
line, which is within the precision of the method 
(CV = 7.2%). At 18 months, fewer global DNA 
hydroxymethylation samples could be quantified 
from blood due to lower DNA yield upon extraction, 
especially from blood samples stored at −20°C 
(Supplementary Table S2).
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Stability after repetitive freezing and thawing
DNA methylation assessed in stored blood or 
extracted DNA upon freezing and thawing fluctu-
ated between 4.23 ± 0.20 and 4.29 ± 0.17 over three 
cycles (Figure 3 and supplementary Table S3), which 
was no significant change (p = 0.7904). Changes 
compared to baseline were all <1%, which is within 
the within-run precision of the method (CV = 1.7%).
For global DNA hydroxymethylation in stored 
blood and extracted DNA samples, mean global 
DNA hydroxymethylation fluctuated between 
0.034 ± 0.005 and 0.036 ± 0.008 upon freezing 
and thawing. Relative differences compared to 
baseline were all <6%. Although, this change was 
significant (p = 0.0169; Supplementary Table S3), 
these differences were within the within-run pre-
cision of our method (CV = 6.3%).
Discussion
For the use of stored samples in epigenetic studies it 
is important to know whether the stability of epige-
netic markers is affected by storage conditions like 
time, material and temperature. In this study, we 
therefore examined the effect of these storage condi-
tions on the stability of DNA methylation and 
hydroxymethylation. We showed that overall global 
DNA methylation and global DNA hydroxymethy-
lation are stable when stored as blood or extracted 
DNA over a period of 18 months. However, storage 
of DNA at −20°C for longer than 12 months led to 
a significant but small decrease of 6.1% in global 
DNA methylation relative to baseline. Global DNA 
hydroxymethylation was more stable in stored DNA 
compared to blood after 6 months, which was inde-
pendent of storage temperature. Furthermore, 
freeze-thaw cycles did not influence the stability of 
global DNA methylation and hydroxymethylation. 
Considering all this, we would recommend to store 
samples as extracted DNA at −80°C.
We have chosen storage temperatures and time 
according to daily practice. Therefore, EDTA blood 
at 4°C was stored for 1 month as in most laboratories 
longer storage takes place at −20°C or −80°C. 
Although global DNA methylation in blood samples 
stored at 4°C for 1 month slightly decreased, this 
decrease was similar to that in blood stored at −20° 
C and −80°C and to DNA samples stored at 4°C 
during the first month, where after mean methyla-
tion in all these conditions increased again towards 
the mean of baseline measurements. These changes 
lay within the precision of the method, indicating 
that these are probably due to between-run 
variances.
Mean DNA methylation levels were comparable 
to previously reported levels quantified by liquid 
chromatography – electrospray ionization – tan-
dem mass spectrometry (LC-ESI-MS/MS) with 
mean DNA methylation between ~2 − 5% and 
hydroxymethylation of ~0.03% [20–22]. These 
DNA methylation levels are also comparable to 
quantification using enzyme-linked immunosor-
bent assay (ELISA) – based methods with mean 
levels in the same range [23]. However, LC-MS has 
been shown to be more specific compared to 
ELISA-based methods [24]. Other methods that 
are used as a proxy for global DNA methylation 
usually measure highly repetitive and densely 
methylated regions, which is the case for long 
interspersed nuclear elements (LINE-1) and short 
interspersed nuclear elements (SINE), together 
constituting of ~30% of the genome. Because 
these regions are highly methylated, quantification 
of DNA methylation results in higher percentages 
(>50%). For the quantification of actual global 
DNA methylation and hydroxymethylation per-
centages LC-MS/MS is the gold standard, while 
for other research questions other methods could 
be considered [24,25].
Few other groups investigated the stability of 
global DNA methylation. One study observed 
a strong decrease in global DNA methylation 
upon three days of whole blood storage at room 
temperature, 4°C and −80°C, assessed using a dot- 
blot assay [16]. They observed a strong decrease in 
DNA methylation, however, this was a small study, 
including 10 subjects only and the decrease was 
accompanied by a decrease in DNA concentration 
due to white blood cell lysis. In another study, the 
authors examined mean methylation of multiple 
CpG sites grouped within specific genomic regions 
(transcription start site, promoter, gene body, CpG 
islands, and shores) assessed by bisulphite conver-
sion followed by pyrosequencing. In line with our 
results, they observed similar methylation patterns 
over time for DNA extracted from stored blood (4° 
C, -80°C) for 20 years and fresh samples. Like in 
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our study, small differences over time were 
observed; however, their study design was cross- 
sectional and ours longitudinal. They observed 
that the variation between fresh samples and 
stored samples was similar, indicating that there 
was no real effect of storage [15]. In our study, we 
observed small differences over time that were 
comparable to the precision of the method, with 
the exception of stored DNA at −20°C after 
12 months and blood after 12 months, here we 
saw a relative decrease in global DNA methylation 
and a relative increase in global DNA hydroxy-
methylation respectively that exceeded the preci-
sion of the method.
In contrast to our study, most studies focused on 
the stability of DNA methylation at candidate genes. 
These results depended on the targeted site, the tech-
nique used and the material stored. Schröder et al. for 
instance observed a strong increase in mean DNA 
methylation in the intron 1 of HIF3A gene of blood 
stored at room temperature, 2–8°C, −20°C and −70°C, 
after 10 months of storage, assessed using bisulphite 
sequencing [17]. While, others did not find significant 
differences in the hypermethylated promoter region of 
testis-specific histone 2B (TSH2B) and the hypo-
methylated transcription start site of glyceraldehyde 
3-phosphate dehydrogenase (GAPDH) quantified 
using methylated DNA immunoprecipitation coupled 
with next-generation sequencing (MeDIP-seq) in 
dried blood spots (DBS) stored at room temperature 
for 16 years compared to freshly extracted material 
[26]. Thus, global DNA methylation is mainly stable 
upon storage, however, changes may occur at gene- 
specific sites.
Finally, stability of global DNA methylation and 
hydroxymethylation were not affected by freezing 
and thawing of blood or DNA samples for at least 
three freeze-thaw cycles at −80°C, which is in accor-
dance with Li and colleagues who observed no effect 
of freeze-thaw cycles on DNA methylation [15]. 
Additionally, to our knowledge we were the first to 
assess the stability of global DNA hydroxymethyla-
tion, thus more studies are required to confirm our 
findings.
Strengths of this study are that this is a longitudinal 
study, excluding potential differences due to inter- 
subject variability over time. Relative to other studies, 
our study groups were large, as most studies assessing 
DNA methylation stability only included 6–10 
subjects per condition. Additionally, for all subjects, 
fresh material was collected and stored at the same 
time, so there was no time-to storage variability 
between the samples and samples from similar mate-
rials were quantified at the same time to reduce 
between-run variability. Additionally, global DNA 
methylation and hydroxymethylation were quantified 
using a global LC-MS/MS method, which is the gold 
standard method for analysis of global DNA methyla-
tion and enables to assess mean stability of methylated 
and hydroxymethylated cytosines all over the genome 
[27]. An advantage of our method over other global 
DNA methylation methods is that no bisulphite con-
version nor whole genome amplification is required to 
distinguish methylated from unmethylated cytosines, 
which minimizes the risk to introduce biases. Also, in 
our study DNA was digested into single nucleotides 
representing cytosines from the whole genome instead 
of a surrogate measure for global DNA methylation, 
like repetitive elements. Additionally, DNA hydroxy-
methylation was quantified simultaneously, which 
allows us to compare DNA methylation and hydro-
xymethylation within the same samples. A limitation 
of the method is that we cannot draw conclusions 
from stability at targeted CpG sites, while methylation 
at some sites have been shown to be more stable than 
others.
Other limitations of our study are that we did 
not account for cell type ratios. From literature, it 
is known that different cell types have different 
(hydroxy)methylomes [28]. Previously, it was sug-
gested that some cell types are more stable than 
others upon storage, which may lead to different 
cell type ratios upon cell lysis and consequently in 
different DNA methylation percentages [17]. 
Although, in our study, this seems unlikely as we 
then would expect to find changes in blood sam-
ples over time and not in stored DNA samples, 
which was not the case.
Conclusion
In conclusion, overall global DNA (hydroxy) 
methylation was stable. However, small significant 
differences over time were observed in global 
DNA methylation and global DNA hydroxy-
methylation upon storage. Therefore, when sam-
ples are stored for extended periods of time or 
when samples are stored for different time 
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durations, small differences in relation to disease 
should be interpreted with caution. Subsequently, 
for the assessment of global DNA (hydroxy) 
methylation, samples can best be stored at −80°C 
as extracted DNA.
Methods
Subjects and study design
EDTA whole blood was collected from leftover blood 
samples of the department of clinical chemistry at the 
Erasmus MC University medical centre of 90 indivi-
duals and divided into three groups of 30 individuals. 
Blood from patients from the oncology department 
was excluded due to the chance of decreased white 
blood cell concentrations, required for DNA extrac-
tion. None of the subjects included in the study 
objected for the use of their material for scientific 
research (opt in-opt out procedure) and all samples 
were anonymized after collection and the study fol-
lows the principles of the Declaration of Helsinki of 
1975. 4 mL EDTA blood of the first 30 subjects 
(group 1) was stored in aliquots of 375 μL. From 
the second group, 4 mL EDTA blood was used to 
extract DNA, where after DNA samples were stored 
in aliquots of 25 μL. Blood and DNA aliquots were 
stored at three different temperatures (4°C, −20°C, 
−80°C) for 1, 6, 12 or 18 months prior to (hydroxy) 
methylation quantification (Figure 1). Blood samples 
stored at 4°C were stored for 1 month, as blood storage 
at this temperature is usually short term. From all 
subjects, one sample was processed and quantified 
immediately, which was used as baseline measure-
ment. From the third group, 1.6 mL EDTA blood 
was collected of which half was used to store blood 
samples and half was used to extract and store DNA. 
Blood and DNA samples of this group were used to 
assess the effect of freeze-thaw cycles over three con-
secutive days after blood collection (0, 1, 2, 3 times) on 
the stability of DNA (hydroxy)methylation. DNA and 
blood samples were frozen at −80°C and thawed at 
room temperature on a laboratory tube roller for 2 
h (=1 cycle) before they were refrozen or further 
processed for DNA (hydroxy)methylation quantifica-
tion. DNA (hydroxy)methylation was quantified 
within the same day in all samples.
DNA extraction
DNA was extracted from EDTA whole blood using 
the MagNA Pure Compact Nucleic Acid Isolation 
Kit I, following manufacturer’s protocol (cat.no: 
03730964001, Roche Molecular Biochemicals®) [10] 
[. DNA concentrations were assessed using 
a NanoDrop ND-1000 Spectrophotometer with 
DNA-50 default settings (NanoDrop Technologies, 
Wilmington, DE, USA).
DNA (hydroxy)methylation quantification
Quantification of DNA (hydroxy)methylation was 
performed using a liquid chromatography – elec-
trospray ionization – tandem mass spectrometry 
(LC-ESI-MS/MS) method, as previously described 
[10][]. To reduce technical variances, a batch sam-
ple of internal standard and a batch calibration 
curve (stored at −80°C) were used for (hydroxy) 
methylation quantification at each time point. For 
hydroxymethylation, samples with analyte areas 
<50 000 were excluded, as these were too low to 
correctly quantify DNA hydroxymethylation. For 
DNA methylation, all areas were above 50 000. As 
Figure 1. Experimental set up of material stored at different temperatures.
EDTA blood of 30 individuals and extracted DNA samples of another 30 individuals were aliquoted and stored at three different 
temperatures for different time durations as indicated. Blood samples stored at 4°C were stored for 1 month only. Baseline samples 
were immediately processed and quantified which is why no storage temperature was given (-). 
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an additional quality check, we assessed the ratios 
between areas of the quantifier and qualifier of 2 - 
deoxyguanosine, as these should be similar 
each day. DNA methylation samples in which 
this ratio deviated >10% from the mean of 
that day, were excluded. A random DNA sample 
was stored in batches of 27 ng/µL at −80°C which 
was used as batch control: these samples were 
digested and quantified in each run together with 
the rest of the samples and acted as quality control. 
The method was previously validated. To deter-
mine precision 5-hmdC/2-dG and 5-mdC/2-dG 
Figure 2. DNA (hydroxy)methylation over time for blood and DNA samples stored at different temperatures.
Mean ± SD DNA methylation (upper panel) and hydroxymethylation (lower panel) quantified in samples stored as blood (solid line) 
or DNA (dashed line). 
Figure 3. Effect of freezing and thawing on the stability DNA (hydroxy)methylation.
Mean percentage DNA methylation (left) and hydroxymethylation (right) for 0 (fresh material), 1, 2 or 3 freeze-thaw cycles. Error bars 
represent the standard deviation. 
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were quantified in fourfold over 5 days in DNA 
samples with low (27 ng/µL) and high (54 ng/µL) 
concentrations. Results of the precision experi-
ment are shown in Table 1. Samples were all 
diluted to 30 ng/µL, hence for this study, we com-
pared samples to the precision of the method for 
the low DNA concentration (27 ng/µL). The 
LLOQ for DNA hydroxy(methylation) was 10 ng/ 
mL, which was determined according to Clinical 
Laboratory and Standards Institute (CLSI) proto-
col EP-17a. To determine the dynamic range of the 
method, a random DNA sample of 27 ng/ul was 
spiked with 6 increasing concentrations, each mea-
sured in quadruple. Linearity was assessed using 
a lack-of-fit test using the Excel plug-in Analyse-it, 
where values <3.29 were considered linear. The 
range and corresponding lack-of-fit measure were 
as follows: 5-hmdC between 5.9 and 36 nM (lack- 
of-fit = 0.16), 5-mdC between 552 and 3553 nM 
(lack-of-fit = 2.47) and 2-dG between 13159 and 
23159 nM (lack-of-fit = 2.22).
Statistics
Percentages of global DNA (hydroxy)methylation 
were presented as mean ± standard deviation (SD). 
Linear mixed models were used to assess changes 
in DNA (hydroxy)methylation over time. Main 
effects included in the models were: temperature, 
material, and time. To assess whether DNA 
(hydroxy)methylation changed differently over 
time for DNA and blood samples stored at differ-
ent temperatures, two and three-way interaction 
terms between temperature, material, and time 
were examined. The models with two-way interac-
tion terms and a model with a three-way interac-
tion term between time, material, and temperature 
were compared using a chi-square log likelihood 
ratio test, where a p-value <0.05 was considered 
a significant difference. Additionally, overall 
model qualities were assessed using the Akaike 
information criterion (AIC), where the lower the 
AIC the better the model fits the data. Here, 
a difference of at least two AIC units was consid-
ered a significantly better fit [29]. Upon signifi-
cance of (higher-term) interactions, all lower-term 
interactions were kept in the model to keep the 
models hierarchically well formulated (HWF) 
[30,31]. Additionally, to assess whether DNA 
(hydroxy)methylation was stable over time, we 
completely removed time from the model and 
compared the model with and without time com-
ponent. Upon a change of ≥2 units in AIC upon 
removal of the time component, time was consid-
ered significantly important for the model, mean-
ing that there are changes over time. Random 
effects included in the model were: (A) random 
intercept for time (accounting for inter-subject 
variability in (hydroxy)methylation levels at base-
line, which may influence stability over time) and 
(B) random slopes for subjects (hydroxymethyla-
tion) or for subjects grouped within storage tem-
perature (methylation), adjusting for the fact that 
samples from the same subject were higher corre-
lated over time than from different subjects. Final 
model for the analysis of DNA methylation over 
time per condition was: lme(fixed = methylation ~ 
material * temperature * time, random = ~time|id/ 
temperature) and for DNA hydroxymethylation: 
lme(fixed = hydroxymethylation ~ temperature + 
material * time, random = ~time|id). For the ana-
lysis of freeze-thaw cycles on the stability of DNA 
(hydroxy)methylation we used a linear mixed 
model including fixed effects for: material and 
number of cycles (cycles) and the following ran-
dom effects: random intercept and random slope 
for subjects (id). Final models for both DNA 
methylation and hydroxymethylation upon freez-
ing and thawing were as follows  lme(data = DF, 
fixed = (hydroxy)methylation ~ material * cycles, 
Table 1. Precision results of method validation.
Component








5-hmdC/2-dG 27 6.3 6.3
54 7.6 7.7
5-mdC/2-dG 27 1.7 2.8
54 1.5 2.5
CV = coefficient of variation 
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random = ~ 1 | id). All analyses were performed in 
R studio (R version 3.6.1 (2019–07-05)) using the 
linear mixed effect model (lme) function of the 
‘nlme’ package and were fitted using the maximum 
likelihood ‘ML’ method [32].
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